LncRNA HOST2 promotes NSUN2-mediated breast cancer progression via interaction with ELAVL1
Cellular Signalling · 2024-05 · 117 · 111112
DOI: 10.1016/j.cellsig.2024.111112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2024-05. Verfasst von Xuehui Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Breast Surgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China; Institute …. Hauptthemen laut MEDLINE: Breast Neoplasms, ELAV-Like Protein 1, Methyltransferases, RNA, Long Noncoding. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Breast cancer (BC) is the most prevalent malignant tumor in women worldwide with high morbidity and mortality. NSUN2, a crucial RNA methyltransferase, plays a pivotal role in regulating the proliferation and metastasis of tumor cells. Our study demonstrated that NSUN2 is upregulated in BC tissues and cell lines, and its high expression is associated with a poor prognosis in BC patients. Knockout of NSUN2 exerted inhibitory effects on the proliferation and migration of BC cells in vitro and in vivo. Mechanistic investigations revealed that the RNA-binding protein ELAVL1 can bind to NSUN2 mRNA and increase its stability. Additionally, we identified HOST2, a long non-coding RNA, as a key player in blocking the ubiquitin-dependent proteasomal degradation of ELAVL1, thereby influencing the stability of NSUN2 mRNA. In conclusion, this study revealed for the first time that HOST2 maintains NSUN2 mRNA stability by blocking ubiquitin-dependent degradation of ELAVL1, which in turn affects BC progression. HOST2/ELAVL1/NSUN2 oncogenic cascade has the potential to be a novel therapeutic target for BC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thyroid and Breast Surgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China; Institute of Breast Disease, School of Medicine, Tongji University, Shanghai 200…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Liu, D., Hua, K., & Fang, L. (2024). LncRNA HOST2 promotes NSUN2-mediated breast cancer progression via interaction with ELAVL1. Cellular Signalling, 117, 111112. https://doi.org/10.1016/j.cellsig.2024.111112
Vancouver
Wang X, Liu D, Hua K, Fang L. LncRNA HOST2 promotes NSUN2-mediated breast cancer progression via interaction with ELAVL1. Cellular Signalling. 2024;117:111112. doi:10.1016/j.cellsig.2024.111112
BibTeX
@article{Wang2024,
author = {Wang, Xuehui and Liu, Diya and Hua, Kaiyao and Fang, Lin},
title = {LncRNA HOST2 promotes NSUN2-mediated breast cancer progression via interaction with ELAVL1},
journal = {Cellular Signalling},
year = {2024},
volume = {117},
pages = {111112},
doi = {10.1016/j.cellsig.2024.111112}
}
EUVIMED